My HPRA: Register

The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


EQUASYMÒ 20 MG TABLETS



Shire Pharmaceuticals Ireland LimitedPA1575/001/006

Main Information

Trade NameEQUASYMÒ 20 MG TABLETS
Active SubstancesMethylphenidate hydrochloride
Dosage FormTablet
Licence HolderShire Pharmaceuticals Ireland Limited
Licence NumberPA1575/001/006

Group Information

ATC CodeN06BA Centrally acting sympathomimetics
N06BA04 methylphenidate

Status

License statusWithdrawn
Withdrawn Date29/04/2019
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (see Summary of Product Characteristics, 4.2). This product contains a substance listed in schedule 2 to the Misuse of Drugs Regulations 2017..
Marketing StatusNot marketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletNo document available
Public Assessment ReportNo document available
« Back
Follow medicine

Print